Analystreport

Catalyst Pharmaceuticals (NASDAQ:CPRX) had its price target raised by analysts at Citigroup Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.

Catalyst Pharmaceuticals, Inc.  (CPRX) 
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.catalystpharma.com